Oruka Therapeutics (ORKA) Preferred Shares Issued (2024)
Oruka Therapeutics' quarterly Preferred Shares Issued came in at -$69000.0 in Q2 2024, down 102.3% quarter-over-quarter from $3.0 million in Q1 2024.
Oruka Therapeutics has reported Preferred Shares Issued for 1 years, with the latest figure at -$69000.0 in Q2 2024.
- For the quarter ending Q2 2024, Preferred Shares Issued changed N/A year-over-year to -$69000.0; the trailing twelve-month figure through Dec 2024 stood at $2.9 million (changed N/A YoY), and the FY2024 full-year result was $2.9 million, changed N/A from the prior year.
- Preferred Shares Issued for Q2 2024 stood at -$69000.0, down from $3.0 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $3.0 million in Q1 2024, with the low at -$69000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -69,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |